Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IRL 757

Next Previous
Drug Profile

IRL 757

Alternative Names: IRL-757

Latest Information Update: 08 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Integrative Research Laboratories
  • Developer Integrative Research Laboratories; The McQuade Center for Strategic Research and Development
  • Class Antiparkinsonians; Neuroprotectants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Parkinson's disease
  • Phase I Neurodegenerative disorders

Most Recent Events

  • 23 Dec 2025 Regulatory body approves IND application for IRL 757 in Parkinson’s Disease
  • 12 Dec 2025 Phase-I/II clinical trials in Parkinson's disease (Treatment-experienced) in Bulgaria, Germany, Spain, Poland (PO) (CTIS2025-523612-37-00) (NCT07461220)
  • 07 May 2025 IRLAB Therapeutics plans a phase I trial for Parkinson’s disease in the second half of 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top